STAAR SURGICAL CO (STAA) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · General / Diversified · as of Jun 27, 2026
STAAR SURGICAL CO (STAA)
A forensic read on STAAR SURGICAL CO built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
4.5
Altman Z-score
Clean
Earnings quality
3
Forensic signals
-6.1%
ROE
$1.5B
Market cap
STAAR SURGICAL CO earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 4.5, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-31%Return on invested capital.Return on invested capital is -31% and slipping from 14% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
+0.1%/yrShare-count dilution.Diluted share count changed +0% over the last 4 years to FY2026 (+0.1%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
13% of revStock-based comp load.Stock-based compensation ran 13% of revenue in FY2026 — about $0.62 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
Key fundamentals
Net Margin-33.6%
Free Cash Flow$-40.0M
Latest Revenue$239.4M
Return on Equity-23.4%
Revenue Growth YoY-23.7%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on STAAR SURGICAL CO:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about STAA's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown